MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/jgh.70421

Медицинская библиотека · Journal of gastroenterology and hepatology · 2026

Efficacy and Safety of Postbiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.

Ayad Mina Ehab, Yu Shiyi, El Shennawy Safia, Al Mowafy Enaam Ali, Sahran Nur-Fazimah, Elwalid-Jad Rawan, Lee Yeong Yeh

СтатьяСистематический обзорМетаанализПеревод пока не подготовлен

Аннотация

BACKGROUND AND AIM: Postbiotics, preparations of inanimate microorganisms and/or their components with health benefits, may offer potential advantages in the management of IBS, but evidence remains limited. We conducted the first systematic review and meta-analysis to assess the efficacy and safety of postbiotics in adults with IBS.

METHODS

PubMed, Scopus, Embase, and Web of Science were searched from inception to August 2025 for randomized controlled trials (RCTs) comparing postbiotics with placebo in adults diagnosed with IBS by Rome III or IV criteria. Primary outcomes were changes in the IBS Symptom Severity Scale (IBS-SSS) and achievement of ≥ 30% abdominal pain reduction. Secondary outcomes included quality of life (QoL) and treatment-emergent adverse events (TEAEs). Risk of bias was assessed using Cochrane RoB 2.0 and certainty of evidence using GRADE. Meta-analyses were conducted using RevMan 5.4.

RESULTS

Four RCTs including 1062 participants were analyzed. Postbiotics significantly reduced IBS-SSS scores compared with placebo (standardized mean difference [SMD] - 1.36, 95% CI -1.75 to -0.97; p < 0.00001). Postbiotics increased the likelihood of achieving a clinically meaningful pain response (risk ratio [RR] 2.46, 95% CI 1.96-3.57; p < 0.00001). QoL improved with oral capsule formulations (SMD 0.84, 95% CI 0.67-1.01; I2 = 0%), but not when an enema-based study was included. TEAE rates were similar between groups (RR 0.68, 95% CI 0.34-1.35; p = 0.27). Heterogeneity was moderate to substantial. Certainty of evidence was low.

CONCLUSIONS

Postbiotics may improve IBS symptom severity and abdominal pain, with oral formulations showing potential QoL benefits and comparable safety to placebo. Larger, standardized RCTs are required to confirm these findings.

Для цитирования: Ayad Mina Ehab, Yu Shiyi, El Shennawy Safia, Al Mowafy Enaam Ali, Sahran Nur-Fazimah, Elwalid-Jad Rawan, Lee Yeong Yeh. Efficacy and Safety of Postbiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.. Journal of gastroenterology and hepatology. 2026. DOI: 10.1111/jgh.70421.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.